Tag Archives: NASDAQ:ADXS

Analysts Offer Insights on Healthcare Companies: Advaxis (NASDAQ: ADXS) and Aerpio Pharmaceuticals Inc (NASDAQ: ARPO)

Analysts fell to the sidelines weighing in on Advaxis (ADXS – Research Report) and Aerpio Pharmaceuticals Inc (ARPO – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. Advaxis (ADXS) In a

A Director at Advaxis (NASDAQ: ADXS) is Buying Shares

Today, a Director at Advaxis (NASDAQ: ADXS), Roni Appel, bought shares of ADXS for $40K. This recent transaction increases Roni Appel’s holding in the company by 26.92% to a total of $128.4K. See today’s analyst top recommended stocks >> Currently,

Analysts Are Bullish on These Healthcare Stocks: ADXS, CCXI

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Advaxis (NASDAQ: ADXS) and ChemoCentryx (NASDAQ: CCXI) with bullish sentiments. Advaxis (NASDAQ: ADXS) In a report released today, Swayampakula Ramakanth from H.C.

Analysts Offer Insights on Healthcare Companies: Advaxis (NASDAQ: ADXS) and Nektar Therapeutics (NASDAQ: NKTR)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Advaxis (NASDAQ: ADXS) and Nektar Therapeutics (NASDAQ: NKTR) with bullish sentiments. Advaxis (NASDAQ: ADXS) In a report released today, Swayampakula Ramakanth from

Cantor Fitzgerald Thinks Advaxis’ Stock is Going to Recover

Cantor Fitzgerald analyst Mara Goldstein maintained a Buy rating on Advaxis (NASDAQ: ADXS) today and set a price target of $19. The company’s shares opened today at $3, close to its 52-week low of $2.71. Goldstein noted: “Closing out 2017

The CFO of Advaxis (NASDAQ: ADXS) is Selling Shares

Yesterday, the CFO of Advaxis (NASDAQ: ADXS), Sara Bonstein, sold shares of ADXS for $12.74K. In addition to Sara Bonstein, 3 other ADXS executives reported Sell trades in the last month. The company has a one-year high of $10.88 and